Auro Laboratories Ltd

Auro Laboratories Ltd

Auro Laboratories Ltd has announced the closure of its trading window for dealing in securities from October 1, 2026, due to the consideration of unaudited financial results for the quarter and half year ended September 30, 2026.

Auro Laboratories Ltd

Auro Laboratories Ltd has submitted the clippings of newspaper publications of the unaudited financial results for the quarter ended June 30, 2026.

Auro Laboratories Ltd

Auro Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 104.56 lakhs and EPS of Rs. 1.68.

Auro Laboratories Ltd

Auro Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 104.56 lakhs and EPS of Rs. 1.68.

Auro Laboratories Ltd

Auro Laboratories Ltd has submitted the Scrutinizer Report of 37th AGM held on August 11, 2026, with all resolutions passed with requisite majority.

Auro Laboratories Ltd

Auro Laboratories Ltd held its 37th Annual General Meeting (AGM) on August 11, 2026, through video conferencing. The meeting was conducted in accordance with the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's financial statements for the year ended March 31, 2026, were adopted, and a director, Mr. Kiran Kulkarni, was re-appointed.

Auro Laboratories Ltd

Auro Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve Unaudited Financial Results for the quarter ended June 30, 2026.